NEXIANGA Trademark

Trademark Overview

On Friday, March 14, 2008, a trademark application was filed for NEXIANGA with the United States Patent and Trademark Office. The USPTO has given the NEXIANGA trademark a serial number of 77422199. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 9, 2016. This trademark is owned by AstraZeneca AB. The NEXIANGA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the fields of cardiovascular diseases and gastrointestinal diseases
nexianga

General Information

Serial Number77422199
Word MarkNEXIANGA
Filing DateFriday, March 14, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 9, 2016
Registration Number3783213
Registration DateTuesday, May 4, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 9, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations in the fields of cardiovascular diseases and gastrointestinal diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 9, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE

Trademark Events

Event DateEvent Description
Friday, December 9, 2016CANCELLED SEC. 8 (6-YR)
Tuesday, May 4, 2010REGISTERED-PRINCIPAL REGISTER
Friday, March 26, 20101(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, March 1, 2010NOTICE OF ALLOWANCE CANCELLED
Thursday, March 11, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 1, 2010TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, September 1, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 9, 2009PUBLISHED FOR OPPOSITION
Wednesday, May 20, 2009NOTICE OF PUBLICATION
Monday, May 4, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 30, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 30, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 30, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 29, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 29, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 29, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, November 18, 2008NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, November 18, 2008INQUIRY TO SUSPENSION E-MAILED
Tuesday, November 18, 2008SUSPENSION INQUIRY WRITTEN
Friday, November 7, 2008LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, November 7, 2008ASSIGNED TO LIE
Thursday, May 15, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 15, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 1, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, May 1, 2008LETTER OF SUSPENSION E-MAILED
Thursday, May 1, 2008SUSPENSION LETTER WRITTEN
Thursday, May 1, 2008ASSIGNED TO EXAMINER
Wednesday, April 2, 2008AMENDMENT FROM APPLICANT ENTERED
Wednesday, April 2, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 2, 2008ASSIGNED TO LIE
Friday, March 28, 2008PAPER RECEIVED
Wednesday, March 19, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

nexianga diseases gastrointestinal cardiovascular fields preparations pharmaceutical